Fresenius Medical Care Deutschland GmbH
- Country
- 🇩🇪Germany
- Ownership
- Public, Subsidiary
- Established
- 1912-01-01
- Employees
- 10K
- Market Cap
- -
Pilot Medical Evaluation of the T50 Test
- Conditions
- Renal FailureCardiovascular DiseasesVascular Calcification
- Interventions
- Diagnostic Test: T50 Calcification Inhibition Test (CIT)
- First Posted Date
- 2017-09-25
- Last Posted Date
- 2022-02-09
- Lead Sponsor
- Fresenius Medical Care Deutschland GmbH
- Target Recruit Count
- 776
- Registration Number
- NCT03292029
- Locations
- 🇪🇸
Centro de Diálisis Barcelona - Diagonal, Barcelona, Spain
🇪🇸Centro de Diálisis Terrassa, Terrassa, Spain
🇪🇸Centro de Diálisis Barcelona - Glories, Barcelona, Spain
HaemoDialysis Interventions to REduce Multi-Organ Dysfunction and Effect on Quality of Life Assessed by MRI Scanning
- Conditions
- Cardiovascular DiseasesCongenital DisordersRenal Failure
- Interventions
- Other: HD, Magnetic Resonance Imaging (MRI) scans
- First Posted Date
- 2017-09-13
- Last Posted Date
- 2021-01-15
- Lead Sponsor
- Fresenius Medical Care Deutschland GmbH
- Target Recruit Count
- 17
- Registration Number
- NCT03280901
- Locations
- 🇬🇧
University of Nottingham, Division of Medical Sciences and Graduate Entry Medicine, Nottingham, United Kingdom
PURE-HF: Peripheral Ultrafiltration for the RElief From Congestion in Heart Failure
- Conditions
- Heart FailureAcute Heart Failure
- Interventions
- Device: CHIARA-SystemOther: Usual care IV diuretics
- First Posted Date
- 2017-05-19
- Last Posted Date
- 2021-05-05
- Lead Sponsor
- Fresenius Medical Care Deutschland GmbH
- Target Recruit Count
- 62
- Registration Number
- NCT03161158
- Locations
- 🇩🇪
Universitätsklinikum Aachen (Med. Klinik II), Aachen, Germany
🇩🇪Helios Klinikum Duisburg, Duisburg, Germany
🇩🇪Helios Klinikum Erfurt GmbH, Erfurt, Germany
Global rEgistry on decongestioN Therapy Using Less invasivE UltraFiltration
- Conditions
- Acute Heart FailureCardiac DecompensationVolume Overload
- Interventions
- Device: periph. minimal invasive ultrafiltration
- First Posted Date
- 2016-05-11
- Last Posted Date
- 2021-08-05
- Lead Sponsor
- Fresenius Medical Care Deutschland GmbH
- Target Recruit Count
- 104
- Registration Number
- NCT02769351
- Locations
- 🇩🇪
Universitätsklinikum Mannheim, Mannheim, Baden-Württemberg, Germany
🇸🇪Falun Hospital, Falun, Sweden
🇩🇪Uniklinik RWTH Aachen, Aachen, North Rhine-Westphalia, Germany
PD-Improved Dialysis Efficiency With Adapted APD
- Conditions
- Chronic Renal Failure
- First Posted Date
- 2015-06-12
- Last Posted Date
- 2020-08-06
- Lead Sponsor
- Fresenius Medical Care Deutschland GmbH
- Target Recruit Count
- 182
- Registration Number
- NCT02470598
- Locations
- 🇫🇮
Regional Hospital Roskilde, Lappeenranta, Finland
🇲🇾Hospital Selayang, Batu Caves, Malaysia
🇲🇾Hospital Universiti Kebangsaan Malaysia (HUKM), Kuala Lumpur, Malaysia
Extracorporeal SPecific IgE Removal From the Plasma of Allergic Asthma Patients (ESPIRA-study)
- Conditions
- Allergic Asthma
- Interventions
- Device: IgE adsorber
- First Posted Date
- 2014-03-26
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- Fresenius Medical Care Deutschland GmbH
- Target Recruit Count
- 14
- Registration Number
- NCT02096237
- Locations
- 🇦🇹
Medical University Vienna, Vienna, Austria
Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules
- Conditions
- HyperphosphatemiaChronic Kidney Disease
- Interventions
- Drug: Osvaren GranulesDrug: Osvaren film-coated tablets
- First Posted Date
- 2014-01-06
- Last Posted Date
- 2015-06-10
- Lead Sponsor
- Fresenius Medical Care Deutschland GmbH
- Target Recruit Count
- 61
- Registration Number
- NCT02027662
- Locations
- 🇩🇪
RWTH University Hospital, Dpt for Nephrology, Aachen, NRW, Germany
🇩🇪Dialysezentrum, Velbert, Germany
🇩🇪Nephro-Studien GbR am Klinikum Erfurt, Erfurt, Germany
Safety and Efficacy of the DALI LDL-adsorber and MONET Lipoprotein Filter
- Conditions
- Hypercholesterolemia, FamilialLIPOPROTEIN TYPES--Lp SYSTEM Lp(a) HYPERLIPOPROTEINEMIA
- Interventions
- Device: DALI-adsorberDevice: MONET-Lipoprotein filter
- First Posted Date
- 2012-12-20
- Last Posted Date
- 2015-09-04
- Lead Sponsor
- Fresenius Medical Care Deutschland GmbH
- Target Recruit Count
- 108
- Registration Number
- NCT01753232
- Locations
- 🇩🇪
Nierenzentrum Mannheim, Mannheim, Baden Würtemberg, Germany
🇩🇪Medizinisches Versorgungszentrum, Kempten, Bayern, Germany
🇩🇪Universitätsklinikum Regensburg Institut für Klinische Chemie und Laboratoriumsmedizin, Regensburg, Bayern, Germany
The Effect of Balance PD Solution on the Peritoneal Membrane in Patients on Automated Peritoneal Dialysis
- Conditions
- Chronic Renal Failure
- Interventions
- Drug: Solution B (balance PD solution)Drug: Solution A (conventional PD solution)
- First Posted Date
- 2012-12-20
- Last Posted Date
- 2016-05-02
- Lead Sponsor
- Fresenius Medical Care Deutschland GmbH
- Target Recruit Count
- 25
- Registration Number
- NCT01753154
- Locations
- 🇵🇱
Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie, Lublin, Poland
🇵🇱Centrum Dializ Fresenius Nephrocare, Gdańsk,, Poland
🇪🇸Complejo hospitalario universitario de Albacete, Albacete, Spain
Application of Citrate Dialysate in Chronic Haemodialysis
- Conditions
- Chronic Renal Disease
- Interventions
- Device: Standard dialysate (StDi)Device: Citrate dialysate (CiDi)
- First Posted Date
- 2012-02-14
- Last Posted Date
- 2014-06-06
- Lead Sponsor
- Fresenius Medical Care Deutschland GmbH
- Target Recruit Count
- 95
- Registration Number
- NCT01532297
- Locations
- 🇩🇪
Städt. Klinikum Solingen gemeinnützige GmbH Klinik für Nephrologie und Allgemeine Innere Medizin, Solingen, Germany
🇩🇪PHV Dialysezentrum, Wetzlar, Germany
🇩🇪Märkische Dialysezentren GmbH, Lüdenscheid, Germany